CA9 and breast cancer: Furthermore, our comprehensive in silico analysis, performed on the annotated breast cancer transcriptomic data (n = 9335), confirmed that the presence of CA IX in breast tumor tissue significantly correlates with ER-, PR-, and HER2+ statuses, and with the highest grade of SBR and NPI (Figure 5 and Figure 6).